TEVA Teva Pharmaceutical Industries Limited

NYSE
$37.09

Teva Pharmaceutical Industries Limited (TEVA) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal Subdued Selling ran below TEVA's own trailing one-year pace, with 63% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 7 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
12
18 transactions
Purchases
$0
0 shares
Sales
$21.3M
606,808 shares
Net activity
-$21.3M
purchases less sales

How much of that selling was preplanned? 63% planned / 37% discretionary

10b5-1 plan sales $13.3M 9 transactions · 380,825 shares
Discretionary sales $7.9M 9 transactions · 225,983 shares

Largest single sale: $5.5M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: September 5, 2025 — 1.0 years ago, by McAvoy David R. .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Weiss Amir 2 fills Chief Accounting Officer Sell 9,445 $37.62 $355.3K 13,071 −41.9% of holding
Satchi-Fainaro Ronit Director Sell 415 $37.25 $15.5K 111,986 −0.4% of holding
Lippman Evan EVP, Business Development Sell 10b5-1 18,600 $36.57 $680.3K 25,591 −42.1% of holding
Zaks Tal Zvi Director Sell 17 $34.87 $593 73,247 −0% of holding
Hughes Eric A See "Remarks" Sell 10b5-1 25,578 $34.88 $892.1K 134,877 −15.9% of holding
Jover Placid See "Remarks" Sell 10b5-1 12,827 $34.88 $447.4K 6,774 −65.4% of holding
Shields Matthew EVP, Global Operations Sell 9,989 $32.19 $321.5K None left
Kalif Eliyahu Sharon EVP, Chief Financial Officer Sell 10b5-1 106,563 $34.10 $3.6M 65,621 −61.9% of holding
Francis Richard D President and CEO Sell 10b5-1 6,153 $34.35 $211.4K 1,177,529 −0.5% of holding
Shields Matthew EVP, Global Operations Sell 10b5-1 16,195 $32.87 $532.3K 9,989 −61.9% of holding
Kalif Eliyahu Sharon EVP, Chief Financial Officer Sell 10b5-1 153,251 $35.61 $5.5M 172,184 −47.1% of holding
Lippman Evan 2 fills EVP, Business Development Sell 10b5-1 41,658 $35.58 $1.5M 44,191 −48.5% of holding
Weiss Amir Chief Accounting Officer Sell 10,679 $36.00 $384.4K 20,016 −34.8% of holding
Daniell Richard EVP, Europe Commercial Sell 30,000 $35.40 $1.1M 55,755 −35% of holding
Sabag Mark See "Remarks" Sell 144,180 $34.99 $5.0M 80,760 −64.1% of holding
Fox Christine EVP, U.S. Commercial Sell 21,258 $35.31 $750.6K 63,647 −25% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.